The deal size was increased to $350M from $300M and priced below last closing price of $65.82. JPMorgan, Goldman Sachs and Evercore ISI are acting as joint book running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on APLS:
- Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
- Apellis offers to sell $300M in common stock
- Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
- Apellis price target raised to $139 from $123 at Raymond James
- Apellis reports Q4 EPS ($1.50), consensus ($1.57)